Jump to main content
Jump to site search

Issue 2, 2020
Previous Article Next Article

Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays

Author affiliations

Abstract

Skin is the largest organ of the body and serves as the principle barrier to the environment. Composed of multiple cell types arranged in stratified layers with highly specialized appendages, it serves sensory and immune surveillance roles in addition to its primary mechanical function. Several complex in vitro models of skin (i.e. microphysiological systems (MPS) including but not limited to 3D tissues, organ-on-a-chip, organoids), have been developed and assays validated for regulatory purposes. As such, skin is arguably the most advanced organ with respect to model development and adoption across industries including chemical, cosmetic, and to a somewhat lesser extent, pharmaceutical. Early adoption of complex skin models and associated assays for assessment of irritation and corrosion spurred research into other areas such as sensitization, absorption, phototoxicity, and genotoxicity. Despite such considerable advancements, opportunities remain for immune capabilities, inclusion of appendages such as hair follicles, fluidics, and innervation, among others. Herein, we provide an overview of current complex skin model capabilities and limitations within the drug development scheme, and recommendations for future model development and assay qualification and/or validation with the intent to facilitate wider adoption of use within the pharmaceutical industry.

Graphical abstract: Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays

Back to tab navigation

Article information


Submitted
01 Jun 2019
Accepted
17 Sep 2019
First published
10 Oct 2019

Lab Chip, 2020,20, 199-214
Article type
Tutorial Review

Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays

R. N. Hardwick, C. J. Betts, J. Whritenour, R. Sura, M. Thamsen, E. H. Kaufman and K. Fabre, Lab Chip, 2020, 20, 199
DOI: 10.1039/C9LC00519F

Social activity

Search articles by author

Spotlight

Advertisements